Pharmacological Interventions to Address Cigarette Smoking in People with Schizophrenia Spectrum Disorders
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Smith P, Zhang J, Weinberger A, Mazure C, McKee S
. Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010-2011 Tobacco Use Supplement to the Current Population Survey. Drug Alcohol Depend. 2017; 178:485-491.
PMC: 6779031.
DOI: 10.1016/j.drugalcdep.2017.05.046.
View
2.
Dickerson F, Bennett M, Dixon L, Burke E, Vaughan C, Delahanty J
. Smoking cessation in persons with serious mental illnesses: the experience of successful quitters. Psychiatr Rehabil J. 2011; 34(4):311-6.
DOI: 10.2975/34.4.2011.311.316.
View
3.
Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P
. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014; 348:g1151.
PMC: 3923980.
DOI: 10.1136/bmj.g1151.
View
4.
Siskind D, Wu B, Wong T, Firth J, Kisely S
. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis. Lancet Psychiatry. 2020; 7(9):762-774.
DOI: 10.1016/S2215-0366(20)30261-3.
View
5.
Rogers E, Sherman S
. Tobacco use screening and treatment by outpatient psychiatrists before and after release of the American Psychiatric Association treatment guidelines for nicotine dependence. Am J Public Health. 2013; 104(1):90-5.
PMC: 3910050.
DOI: 10.2105/AJPH.2013.301584.
View